These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21916798)

  • 1. A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis.
    Sala G; Tremolizzo L; Melchionda L; Stefanoni G; Derosa M; Susani E; Pagani A; Perini M; Pettini P; Tavernelli F; Zarcone D; Ferrarese C
    Amyotroph Lateral Scler; 2012 Jan; 13(1):119-24. PubMed ID: 21916798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis.
    Puentes F; Topping J; Kuhle J; van der Star BJ; Douiri A; Giovannoni G; Baker D; Amor S; Malaspina A
    J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):274-8. PubMed ID: 24078718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Mitochondrial Function, Biogenesis, and Degradation in Peripheral Blood Mononuclear Cells from Amyotrophic Lateral Sclerosis Patients as a Potential Tool for Biomarker Research.
    Araujo BG; Souza E Silva LF; de Barros Torresi JL; Siena A; Valerio BCO; Brito MD; Rosenstock TR
    Mol Neurobiol; 2020 Dec; 57(12):5084-5102. PubMed ID: 32840822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).
    Mandrioli J; Crippa V; Cereda C; Bonetto V; Zucchi E; Gessani A; Ceroni M; Chio A; D'Amico R; Monsurrò MR; Riva N; Sabatelli M; Silani V; Simone IL; Sorarù G; Provenzani A; D'Agostino VG; Carra S; Poletti A
    BMJ Open; 2019 May; 9(5):e028486. PubMed ID: 31152038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation.
    Arosio A; Cristofani R; Pansarasa O; Crippa V; Riva C; Sirtori R; Rodriguez-Menendez V; Riva N; Gerardi F; Lunetta C; Cereda C; Poletti A; Ferrarese C; Tremolizzo L; Sala G
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):51-62. PubMed ID: 31663379
    [No Abstract]   [Full Text] [Related]  

  • 8. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.
    Rusmini P; Cortese K; Crippa V; Cristofani R; Cicardi ME; Ferrari V; Vezzoli G; Tedesco B; Meroni M; Messi E; Piccolella M; Galbiati M; Garrè M; Morelli E; Vaccari T; Poletti A
    Autophagy; 2019 Apr; 15(4):631-651. PubMed ID: 30335591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood oxidative stress in amyotrophic lateral sclerosis.
    Bonnefont-Rousselot D; Lacomblez L; Jaudon M; Lepage S; Salachas F; Bensimon G; Bizard C; Doppler V; Delattre J; Meininger V
    J Neurol Sci; 2000 Sep; 178(1):57-62. PubMed ID: 11018250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of regulatory T lymphocytes and IL2Ra and FOXP3 gene expression in peripheral mononuclear cells from patients with amyotrophic lateral sclerosis.
    Rashid Chehreh Bargh S; Tafakhori A; Masoumi F; Rahmani F; Ahmadi M; Namdar A; Azimi M; Tavasolian P; Habibi S; Zamani B; Maserrat M; Sadr M; Noorbakhsh F; Rezaei N
    Ir J Med Sci; 2018 Nov; 187(4):1065-1071. PubMed ID: 29574662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The autophagy/lysosome pathway is impaired in SCA7 patients and SCA7 knock-in mice.
    Alves S; Cormier-Dequaire F; Marinello M; Marais T; Muriel MP; Beaumatin F; Charbonnier-Beaupel F; Tahiri K; Seilhean D; El Hachimi K; Ruberg M; Stevanin G; Barkats M; den Dunnen W; Priault M; Brice A; Durr A; Corvol JC; Sittler A
    Acta Neuropathol; 2014 Nov; 128(5):705-22. PubMed ID: 24859968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of amyotrophic lateral sclerosis with riluzole.
    Neatherlin JS
    J Neurosci Nurs; 1998 Aug; 30(4):257-60. PubMed ID: 9791781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward more efficient clinical trials for amyotrophic lateral sclerosis.
    Cudkowicz ME; Katz J; Moore DH; O'Neill G; Glass JD; Mitsumoto H; Appel S; Ravina B; Kieburtz K; Shoulson I; Kaufmann P; Khan J; Simpson E; Shefner J; Levin B; Cwik V; Schoenfeld D; Aggarwal S; McDermott MP; Miller RG
    Amyotroph Lateral Scler; 2010 May; 11(3):259-65. PubMed ID: 19961263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.